PYLERA-1 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

PYLERA-1
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

Evonik

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

xyz-pharma-m-2025-02-24

Contact Supplier

PYLERA-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 16 USDMF, 13 CEP/COS, 1 JDMF, 1 EU WC, 14 KDMF, 11 NDC API, 19 Listed Suppliers, $ API Reference Price

39 API Suppliers
16 USDMF
13 CEP/COS
1 JDMF
1 EU WC
14 KDMF
11 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

FINISHED DOSAGE FORMULATIONS

398 FDF Dossiers, 118 FDA Orange Book, 87 Europe, 18 Canada, 14 Australia, 48 South Africa, 113 Listed Dossiers

398 FDF Dossiers
118 FDA Orange Book
87 Europe
18 Canada
14 Australia
48 South Africa
113 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/100ML, INJECTABLE;INJECTION - 500MG/100ML, GEL;TOPICAL - 0.75%, GEL;VAGINAL - 0.75%, GEL;VAGINAL - 1.3%, CREAM;TOPICAL - 0.75%, SUSPENSION;ORAL - 500MG/5ML, GEL;TOPICAL - 1%

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 500MG/100ML
INJECTABLE;INJECTION - 500MG/100ML
GEL;TOPICAL - 0.75%
GEL;VAGINAL - 0.75%
GEL;VAGINAL - 1.3%
CREAM;TOPICAL - 0.75%
SUSPENSION;ORAL - 500MG/5ML
GEL;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 1 Clariant, 17 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Lubrizol Life Science Health, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 45 Thickeners and Stabilizers, 39 Solubilizers, 34 Topical, 34 Controlled & Modified Release, 32 Direct Compression, 30 Disintegrants & Superdisintegrants, 27 Granulation, 23 Film Formers & Plasticizers, 20 Parenteral, 19 Lubricants & Glidants, 17 Taste Masking, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

77 Fillers, Diluents & Binders
49 Coating Systems & Additives
45 Thickeners and Stabilizers
39 Solubilizers
34 Topical
34 Controlled & Modified Release
32 Direct Compression
30 Disintegrants & Superdisintegrants
27 Granulation
23 Film Formers & Plasticizers
20 Parenteral
19 Lubricants & Glidants
17 Taste Masking
14 Co-Processed Excipients
11 Chewable & Orodispersible Aids
9 Empty Capsules
8 Emulsifying Agents
7 Rheology Modifiers
6 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 56 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
56 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 83 Regulatory FDF Prices

6 US Medicaid Prescriptions
83 Regulatory FDF Prices

MARKET PLACE

71 APIs, 40 FDF Dossiers

71 APIs
40 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 5 Health Canada Patents

8 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 11 Others

4 EDQM
2 USP
11 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 11 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 7CHEMO RESEARCH SL

02 1SAPTALIS PHARMS

filter Patent Number Reset all filters

8 All

01 17893097

02 18658678

03 18877792

04 18946276

05 19198858

06 110238634

07 110596155

08 111541035

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 5Y

02 3Blank

filter Expiration Date Reset all filters

8 All

01 12028-02-02

02 12028-02-19

03 12028-06-27

04 42032-06-28

05 12039-10-04

Product Main Page

01

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-28

METRONIDAZOLE

US Patent Number : 9198858

Drug Substance Claim :

Drug Product Claim :

Application Number : 205223

Patent Use Code : U-1664

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2032-06-28

Portfolio PDF

Product Web Link

Digital Content

02

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-27

METRONIDAZOLE

US Patent Number : 8658678

Drug Substance Claim :

Drug Product Claim :

Application Number : 205223

Patent Use Code : U-1682

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2028-06-27

Portfolio PDF

Product Web Link

Digital Content

03

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-28

METRONIDAZOLE

US Patent Number : 8946276

Drug Substance Claim :

Drug Product Claim :

Application Number : 205223

Patent Use Code : U-1664

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2032-06-28

Portfolio PDF

Product Web Link

Digital Content

04

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-19

METRONIDAZOLE

US Patent Number : 7893097

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-19

Portfolio PDF

Product Web Link

Digital Content

05

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-02

METRONIDAZOLE

US Patent Number : 8877792

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-02

Portfolio PDF

Product Web Link

Digital Content

06

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-28

METRONIDAZOLE

US Patent Number : 10238634

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-28

Portfolio PDF

Product Web Link

Digital Content

07

CHEMO RESEARCH SL

World ADC London

Not Confirmed

CHEMO RESEARCH SL

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-28

METRONIDAZOLE

US Patent Number : 10596155

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-28

Portfolio PDF

Product Web Link

Digital Content

08

SAPTALIS PHARMS

World ADC London

Not Confirmed

SAPTALIS PHARMS

World ADC London

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-04

METRONIDAZOLE

US Patent Number : 11541035

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216755

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!